A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition

Objectives : To investigate the underlying mechanisms of how the basic fibroblast growth factor monoclonal antibody (bFGFmAb) attenuates cisplatin (DDP) resistance in lung cancer using A549 cells and cisplatin-resistant A549 cells (A549/DDP). Methods : Cancer cell proliferation, cell viability, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Penghui, So, Kaman, Chen, Hongjie, Lin, Qimou, Xu, Meng, Lin, Yiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168941/
https://www.ncbi.nlm.nih.gov/pubmed/35649742
http://dx.doi.org/10.1177/03946320221105134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168941/
https://www.ncbi.nlm.nih.gov/pubmed/35649742
http://dx.doi.org/10.1177/03946320221105134

Ejemplares similares